BUY Cohance Lifesciences Limited — Shrikant Chouhan, Kotak Securities
byShrikant Chouhan, Kotak SecuritiesHorizon: NA (inferred Swing (≤2wk))28 Oct 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·28 Oct · today
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·18 Aug · 2mo ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Cohance Lifesciences
- BUY — Arun Kumar Mantri21 Oct 2026 · ~2 weeks · target ₹495 · SL hit
- BUY — Investec India21 Oct 2026 · ~1 year · target ₹560 · Active
- BUY — IDBI Capital7 Oct 2026 · ~2 weeks · target ₹490 · SL hit
- BUY — Amit Shreeram Goel21 Aug 2026 · ~2 weeks · target ₹533 · Expired
- BUY — Mehul Kothari, Anand Rathi20 Aug 2026 · ~3 months · target ₹550 · SL hit
More from Shrikant Chouhan, Kotak Securities
- BUY TVS Motor Company28 Oct 2026 · ~2 weeks · target ₹4,400 · Active
- BUY Union Bank of India28 Oct 2026 · ~2 weeks · target ₹195 · Active
- BUY ICICI Bank27 Oct 2026 · ~1 year · target ₹1,800 · Active
- BUY FSN E-Commerce Ventures27 Oct 2026 · ~3 months · target ₹370 · Active
- BUY Sai Life Sciences27 Oct 2026 · ~2 weeks · target ₹1,550 · Active

